Parallel Trade in Polish Pharma: The Good and the Bad
Poland’s entrance into the EU has been a catalyst for growth that has allowed the country to flourish, shown by the nation’s ranking as the eighth largest economy in Europe according…
Address: ul. Zbąszyńska 3 91-342 Łódź
,Poland
Tel: +48 (42) 61 33 444
Web: http://www.pelion.eu/s/60
PGF is the leading company working in healthcare business, concentrating on drug and medical products supply. It derives from 1990 when Mr. Jacek Szwajcowski established the pharmaceutical wholesale – MEDICINES. It was designed to help to transform polish pharma-services into a modern, efficient and quality-driven system.
When wholesale trade in pharmaceuticals was deregulated, it became clear that top market standards could only be achieved by a large organisation with nationwide coverage. Thanks to a series of mergers and acquisitions, PGF has become such a company.
As the most popular domestic wholesale distributor of pharmaceuticals, we have optimised our nationwide sales network. We offer 18 thousand different types of pharmaceutical items from every single existing pharmacological group. We don’t just stop at pharmaceuticals. We sell medical equipment, herbal preparations, and cosmetics. Pharmaceutical sales is PGF’s main revenue (more than 90%), and its share is growing continually. At present, our objective is to harness the opportunities emerging in the ever expanding pharmaceuticals market in Poland.
PGF, the decision making headquarters, manages contact with drug makers and distribution within the PGF group through two branches, in Łódź and Katowice. Thanks to our centralised procurement and given the scale of the Group’s operations, we have been able to secure advantageous supply agreements, which in turn enables us to offer the most attractive service to our customers.
The pharmaceutical distribution is carried out by our subsidiary companies located throughout the whole country. This helps us to maintain a strong position on all the local markets.
PGF also distributes pharmaceuticals to hospitals. Our excellent range on offer and efficient customer service has made us the unquestionable market leader in this segment, supplying one in every three pharmaceutical items used for in-patient health care.
PGF’s strong market position is beneficial to smaller companies also active in pharmaceutical distribution. With annual revenues of more than bilion, PGF as the largest private company established in post-communism Poland ranks among the 100 biggest Central&Eastern Europe companys.
The strategic objective of the Group is to become the leader in Central and Eastern Europe, by consolidating the retail markets in countries of the region. The Group operates in the healthcare sector in Poland and Lithuania. Its services cover all market segments (wholesale, retail sale and sale to hospitals) and are targeted at individual patients, pharmacies, hospitals and manufacturers.
Poland’s entrance into the EU has been a catalyst for growth that has allowed the country to flourish, shown by the nation’s ranking as the eighth largest economy in Europe according…
“Cost containment measures are not just a Polish story, but a European reality,” says Marcin Hanczaruk, general manager at Amgen. “The Reimbursement Act is a real revolution, but it has…
The general director of Actavis Poland talks about competing in an intense generics market, and the company’s potential in Poland given the country’s 2012 Reimbursement Act. The year 2012 was…
AstraZeneca’s General Manager in Poland discuses AstraZeneca’s strategic realignment to become a highly specialized biotech company after 20 years of presence in Poland. He stresses the importance of the affiliate’s…
Novascon Pharmaceuticals is the second fastest growing company in the OTC/dietary supplement market in Poland. Its founder shares the reasons behind this success, including his strategy to sell their main…
Omega Pharma is a pharmacist champion and one of the fastest growing OTC companies in Poland. Its General Manager in Poland discusses the shift taking place with Pharmacies now becoming…
Schulke Poland’s General Manager wants the affiliate: “to be recognized as a high quality “one stop shop” for hygiene and disinfection. He also comments: “Poland is quite advanced in terms…
The department of innovation and industry under the Ministry of Economy has been preparing a new project called: “Pharmaceutical Industry Mapping.” Its leader hopes: “that the outcome of this exercise…
Bristol-Myers Squibb’s General Manager in Poland stresses the urgent need to allow more innovative drugs to fight against deadly diseases, especially in the field of immune-oncology which he says will:…
Unipharm Poland’s country manager explains what is needed to become a successful OTC and dietary supplement company in Poland, saying that it is “key to master the marketing mix but…
Budget limitations in the Polish vaccine field are a handicap to improving patients’ lives as Sanofi Pasteur General Manager comments: “the National Health Fund’s budget for reimbursement is around EUR…
“Innovation is about bringing new chemical compounds on the market; but it is also, and sometimes even more, to continue the therapeutic development of the drugs which are already there”…
See our Cookie Privacy Policy Here